De CenzoJ. M., HowardP., IrishC. E.: Antigenic deletion and prognosis in patients with stage A transitional cell bladder carcinoma. J. Urol., 114; 874 (1975).
2.
BonfiglioT. A., FeinbergR. M.: Isoantigen loss in cervical neoplasia. Demonstration by immunofluorescence and immunoperoxidase techniques. Arch. Pathol. Lab. Med., 100; 307 (1976).
3.
CooperH. S., HaeslerW. E.: Blood group substances as tumor antigens in the distal colon. Amer. J. Clin. Pathol., 69; 584 (1978).
4.
DavidsohnI., NiL. Y.: Loss of isoantigens A, B and H in carcinoma of the lung. Amer. J. Pathol., 57; 307 (1969).
5.
LangeP. H., LimasC., FraleyE. E.: Tissue bood-group antigens and prognosis of low-stage transitional cell carcinoma of the bladder. J. Urol., 119; 52 (1978).
6.
BergmanS., JavadpourN.: The cell surface antigen A, B or O (H) as an indicator of malignant potential in stage A bladder carcinoma. J. Urol., 119; 49 (1978).
7.
JakseG., HofstadterF.: Further experience with the specific red cell adherence test (SRCA) in bladder cancer. Eur. Urol., 4; 356 (1978).
8.
YoungA. R., HammondE., MiddletonA. W.jr.: The prognostic value of cell surface antigens in low grade, non invasive transitional cell carcinoma of the bladder. J. Urol., 122; 462 (1979).
9.
EmmottR. C., JavadpourN., BergmanS. M., SoaresR. T.: Correlation of cell surface antigens with stage and grade in cancer of the bladder. J. Urol., 121; 37 (1979).
10.
RichieJ. P., BluteR. D., WaismanJ.: Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens. J. Urol., 123; 22 (1980).
11.
JohnsonJ. D., LammD. L.: Prediction of bladder tumor invasion with the mixed cell agglutination test. J. Urol., 123; 25 (1980).
12.
NewmanA. J.jr., CarltonC. E.jr., JohnsonS.: Cell surface A, B or O (H) blood group antigens as an indicator of malignant potential in stage a bladder carcinoma. J. Urol., 124; 27 (1980).
13.
AlroyJ., TeramuraK., DavidsohnI., WeinsteinR. S.: A method for demonstrating blood group isoantigens in permanent tissue sections. Stain Technol., 53; 53 (1978)
14.
DavidsohnI.: Early immunologic diagnosis and prognosis of carcinoma. Amer. J. Clin. Pathol., 57; 715 (1972).
15.
CooperH. S., D'EliaF. L.: Comparison between the methods of indirect immunofluorescence and specific red cell adherence in detecting ABH iso-antigens in bladder carcinoma. Amer. J. Clin. Pathol., 77; 584 (1982).
16.
De LellisR. A.: Diagnostic immunochemistry. p. 239–261. Masson, New York 1981.
17.
CoonJ. S., WeinsteinR. S.: Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Amer. J. Clin. Pathol., 76; 163 (1981).
18.
FujitaJ., MatsumodoK., KishiK., IshiyamaI.: Synthesis of ABH blood group substances in bladder tumours. Brit. J. Urol., 53; 448 (1981).
19.
CatalonaW. J.: Practical utility of specific red cell adherence test in bladder cancer. Urology, 18; 113 (1981).
20.
SelliC., CozzolinoF., VercelliD., MincioneG. P.: A, B, O (H) antigenic determinants in superficial transitional cell tumors of the bladder. Urology, 21; 132 (1983).